Top 5 Pharmacy Times Reimbursement Articles of 2023
From newsworthy moments to groundbreaking research, these were the most-read reimbursement-related articles on Pharmacy Times in 2023.
1. Removing Medicaid Prior Authorizations for Buprenorphine May Not Increase Prescribing
Non-expansion states had an increase of 27.3% in prescriptions after prior authorization removal, whereas Medicaid expansion states demonstrated a 22% decrease in prescriptions. Read More Here.
adragan - stock.adobe.come
2. DIR Fee Reform Will Have Repercussions in 2024, But Pharmacists Can Prepare
Managing cost savings can soften the blow of direct and indirect remuneration fee reform that will impact pharmacists during the first half of 2024. Read More Here.
3. Cap on Out-of-Pocket Insulin Costs in Inflation Reduction Act Increased Prescription Fills
Thousands more people filled their insulin prescriptions following the introduction of the cap in January 2023, especially compared to those who were not enrolled in Medicare, a new study finds. Read More Here.
4. New Paper Urges CMS to Reconsider Anti-Obesity Medications as Treatment for Chronic Disease
Current federal statutes exclude anti-obesity medications for coverage when used for anorexia, weight loss, or weight gain. Read More Here.
5. Report Finds Health-System Workforce Challenges Influence Work of Pharmacists, Technicians
Nearly 84% of hospitals are working to prevent and mitigate burnout, with increased support and programs for individual wellness and resilience practices. Read More Here.
